Tofflon Science and Technology Group Co., Ltd. (300171.SZ)
- Previous Close
13.35 - Open
13.52 - Bid 13.72 x --
- Ask 13.75 x --
- Day's Range
13.25 - 13.78 - 52 Week Range
11.70 - 25.82 - Volume
6,872,403 - Avg. Volume
6,516,071 - Market Cap (intraday)
10.461B - Beta (5Y Monthly) 0.59
- PE Ratio (TTM)
17.41 - EPS (TTM)
0.79 - Earnings Date --
- Forward Dividend & Yield 0.33 (2.38%)
- Ex-Dividend Date Jun 29, 2023
- 1y Target Est
--
Tofflon Science and Technology Group Co., Ltd. operates as a pharmaceutical equipment supplier for the pharma and biotech industries worldwide. It offers injectables, such as auto solution preparation systems, aseptic filling lines for ampoule, vials, syringes and powders, freeze dryer and auto loading systems, barrier systems, and plastic packaging machines. The company also provides active pharmaceutical ingredients; and visual inspection, leak detection, and combination systems, as well as focuses on providing bio-process equipment and integrated systems, including medium preparation, cell/microbial cultivation, harvesting, DF/UF, purification, buffer preparation, and finished filling systems. In addition, it offers lyophilization injectable lab services. The company was formerly known as Shanghai Tofflon Science and Technology Co., Ltd. Tofflon Science and Technology Group Co., Ltd. was founded in 1993 and is based in Shanghai, China.
www.tofflon.com5,716
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Related News
Performance Overview: 300171.SZ
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 300171.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 300171.SZ
Valuation Measures
Market Cap
10.46B
Enterprise Value
7.63B
Trailing P/E
17.41
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.85
Price/Book (mrq)
1.33
Enterprise Value/Revenue
1.35
Enterprise Value/EBITDA
9.55
Financial Highlights
Profitability and Income Statement
Profit Margin
10.64%
Return on Assets (ttm)
2.83%
Return on Equity (ttm)
8.21%
Revenue (ttm)
5.64B
Net Income Avi to Common (ttm)
600.24M
Diluted EPS (ttm)
0.79
Balance Sheet and Cash Flow
Total Cash (mrq)
3.05B
Total Debt/Equity (mrq)
0.09%
Levered Free Cash Flow (ttm)
-1.11B
Research Analysis: 300171.SZ
Company Insights: 300171.SZ
300171.SZ does not have Company Insights